A multicenter research team will investigate differences in genetics, epigenetics and cell biology between males and females, with the goal of more-personalized therapy approaches for glioblastoma.
A top heart society has issued recommendations that address women’s unique risk factors in addition to conventional risks. The lead author shares key takeaways.
Emerging sex differences in multiple aspects of this lethal brain cancer likely help explain the disease’s more favorable incidence and prognosis in females. And they may point to new targeted therapies.